Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1284

1.

Anti-Obesity Therapy: from Rainbow Pills to Polyagonists.

Müller TD, Clemmensen C, Finan B, DiMarchi RD, Tschöp MH.

Pharmacol Rev. 2018 Oct;70(4):712-746. doi: 10.1124/pr.117.014803. Review.

PMID:
30087160
2.

Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs.

Dalwadi DA, Ozuna L, Harvey BH, Viljoen M, Schetz JA.

Pharmacol Rev. 2018 Jul;70(3):684-711. doi: 10.1124/pr.117.013706. Review.

PMID:
29945900
3.

Modulating Neural Circuits with Transcranial Magnetic Stimulation: Implications for Addiction Treatment Development.

Hanlon CA, Dowdle LT, Henderson JS.

Pharmacol Rev. 2018 Jul;70(3):661-683. doi: 10.1124/pr.116.013649. Review.

PMID:
29945899
4.

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, Pereira EFR, Albuquerque EX, Thomas CJ, Zarate CA Jr, Gould TD.

Pharmacol Rev. 2018 Jul;70(3):621-660. doi: 10.1124/pr.117.015198. Review.

5.

Trace Amines and Their Receptors.

Gainetdinov RR, Hoener MC, Berry MD.

Pharmacol Rev. 2018 Jul;70(3):549-620. doi: 10.1124/pr.117.015305. Review.

PMID:
29941461
6.

Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases.

Yeung J, Li W, Holinstat M.

Pharmacol Rev. 2018 Jul;70(3):526-548. doi: 10.1124/pr.117.014530. Review.

PMID:
29925522
7.

Mechanisms and Drug Development in Atrial Fibrillation.

Calvo D, Filgueiras-Rama D, Jalife J.

Pharmacol Rev. 2018 Jul;70(3):505-525. doi: 10.1124/pr.117.014183. Review.

PMID:
29921647
8.

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets.

Caraci F, Calabrese F, Molteni R, Bartova L, Dold M, Leggio GM, Fabbri C, Mendlewicz J, Racagni G, Kasper S, Riva MA, Drago F.

Pharmacol Rev. 2018 Jul;70(3):475-504. doi: 10.1124/pr.117.014977.

PMID:
29884653
9.

Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease.

Squires KE, Montañez-Miranda C, Pandya RR, Torres MP, Hepler JR.

Pharmacol Rev. 2018 Jul;70(3):446-474. doi: 10.1124/pr.117.015354. Review.

PMID:
29871944
10.

Current Challenges and Opportunities in Treating Glioblastoma.

Shergalis A, Bankhead A 3rd, Luesakul U, Muangsin N, Neamati N.

Pharmacol Rev. 2018 Jul;70(3):412-445. doi: 10.1124/pr.117.014944.

11.

Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption.

Nehlig A.

Pharmacol Rev. 2018 Apr;70(2):384-411. doi: 10.1124/pr.117.014407. Epub 2018 Mar 7. Review.

PMID:
29514871
12.

Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach.

Cuadrado A, Manda G, Hassan A, Alcaraz MJ, Barbas C, Daiber A, Ghezzi P, León R, López MG, Oliva B, Pajares M, Rojo AI, Robledinos-Antón N, Valverde AM, Guney E, Schmidt HHHW.

Pharmacol Rev. 2018 Apr;70(2):348-383. doi: 10.1124/pr.117.014753. Review.

PMID:
29507103
13.

Etiology and Pharmacology of Neuropathic Pain.

Alles SRA, Smith PA.

Pharmacol Rev. 2018 Apr;70(2):315-347. doi: 10.1124/pr.117.014399. Review.

PMID:
29500312
14.
15.

Biomarkers for In Vivo Assessment of Transporter Function.

Müller F, Sharma A, König J, Fromm MF.

Pharmacol Rev. 2018 Apr;70(2):246-277. doi: 10.1124/pr.116.013326. Review.

PMID:
29487084
16.

Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery.

Atkin T, Comai S, Gobbi G.

Pharmacol Rev. 2018 Apr;70(2):197-245. doi: 10.1124/pr.117.014381. Review.

PMID:
29487083
17.

International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function.

Kennedy AJ, Davenport AP.

Pharmacol Rev. 2018 Jan;70(1):174-196. doi: 10.1124/pr.116.013177. Epub 2017 Dec 26. Review.

18.

Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies.

Oyrer J, Maljevic S, Scheffer IE, Berkovic SF, Petrou S, Reid CA.

Pharmacol Rev. 2018 Jan;70(1):142-173. doi: 10.1124/pr.117.014456. Review.

PMID:
29263209
19.

WNT Signaling in Cardiac and Vascular Disease.

Foulquier S, Daskalopoulos EP, Lluri G, Hermans KCM, Deb A, Blankesteijn WM.

Pharmacol Rev. 2018 Jan;70(1):68-141. doi: 10.1124/pr.117.013896. Review.

PMID:
29247129
20.

G Protein-Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus.

Riddy DM, Delerive P, Summers RJ, Sexton PM, Langmead CJ.

Pharmacol Rev. 2018 Jan;70(1):39-67. doi: 10.1124/pr.117.014373. Review.

PMID:
29233848

Supplemental Content

Loading ...
Support Center